Content of Mucosal Barrier Components in Blood during the Development of Experimental Colitis

Scritto il 14/11/2026
da V A Sorokin

Bull Exp Biol Med. 2026 Nov 14. doi: 10.1007/s10517-026-06765-z. Online ahead of print.

ABSTRACT

The integrity of the intestinal mucosal barrier is a critical protective factor against inflammation. In the diagnosis of mucosal injury associated with inflammatory bowel disease, the proteins I-FABP and TFF2 are particularly promising markers. We investigated the dynamics of these markers, lipid metabolism parameters, and blood adipokine concentrations using a mouse model of DSS-induced colitis. It was found that the acute phase of inflammation (day 14) is characterized by a sharp increase in I-FABP, TFF2, and proinflammatory adipokine leptin. At the peak of the chronic phase (day 60), I-FABP levels decline, while TFF2 continues to rise, reflecting extensive enterocyte damage and the simultaneous activation of reparative mechanisms. In parallel, a significant impairment of the endocrine function of the adipose tissue was revealed, manifested by an increase in leptin and a decrease in anti-inflammatory adiponectin levels. By day 90, a trend toward normalization of these parameters was noted. Our findings confirm the utility of I-FABP and TFF2 as markers of mucosal barrier damage and demonstrate their correlation with systemic metabolic disturbances in colitis.

PMID:43033388 | DOI:10.1007/s10517-026-06765-z